Atlas Trials

Panobinostat and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma

Clinical trial NCT00962507 · COMPLETED

Trial details

NCT number
NCT00962507
Sponsor
City of Hope Medical Center
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
LymphomaMultiple Myeloma and Plasma Cell Neoplasm
Start date
2009-07-01
Primary completion
2013-01-01
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.